Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival
1998 ◽
Vol 23
(4)
◽
pp. 248-253
◽
2014 ◽
Vol 21
(2)
◽
pp. 103-110
◽
2012 ◽
Vol 5
(1)
◽
pp. 150-154
◽
2009 ◽
Vol 13
(9b)
◽
pp. 3985-3992
◽
2009 ◽
Vol 24
(04)
◽